Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cysteinyl-tRNA Synthetase (CARS) (N-Term) Peptide

CARS Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN974468

Quick Overview for Cysteinyl-tRNA Synthetase (CARS) (N-Term) Peptide (ABIN974468)

Target

CARS (Cysteinyl-tRNA Synthetase (CARS))

Origin

Human

Source

  • 8
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-CARS antibody (Catalog #: ARP40298_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CARS (Cysteinyl-tRNA Synthetase (CARS))

    Background

    CARS is a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. CARS gene is one of several loca

    Alias Symbols: CARS1, CYSRS, MGC:11246

    Protein Interaction Partner: EEF1G,EEF1G,PACSIN1,PACSIN2,PACSIN3,PSTPIP1

    Protein Size: 738

    Molecular Weight

    84 kDa

    Gene ID

    833

    NCBI Accession

    NM_001014438, NP_001014438

    UniProt

    A8MVQ3
You are here:
Chat with us!